Skip to main content
. 2023 Nov 27;7(12):953–958. doi: 10.1002/jgh3.13010

Table 1.

Baseline characteristics

All patients (n = 155) CD (n = 81) UC (n = 67) IBD‐U (n = 7)
Sex (% male) 45 46 43 71
Age (median, years) [IQR] 38 [25–52] 34 [23–50] 38 [28–54] 57 [50–60]
Disease duration (median, years) [IQR] 5.9 [2.3–12] 7.8 [2.6–15] 4.6 [1.2–11] 4.9 [2.8–7.5]
Biologic therapy (%) 46 52 50 N/A
Vitamin D supplementation (%) 25 13 13 N/A

Data available only for one patient with IBD‐U.

CD, Crohn's disease; IBD‐U, inflammatory bowel disease unclassified; IQR, interquartile range; UC, ulcerative colitis.